"Multiple outlets report that the forthcoming HHS autism report led by Robert F. Kennedy Jr. is expected to suggest that acetaminophen use in pregnancy is linked to autism and to highlight low folate levels, while pointing to folinic acid (leucovorin) as a potential way to reduce symptoms for some individuals with autism, according to people familiar with the draft cited by the Wall Street Journal, which was first to report the news."
"Fortune Well has contextualized RFK Jr.'s broader claims by reporting his focus on "environmental toxins" as key drivers of rising autism diagnoses, framing his assertions amid scientific uncertainty on specific non-genetic causes. Fortune Well also scrutinized RFK Jr.'s earlier "MAHA report," reporting that it cited nonexistent or misinterpreted studies, signaling concerns about rigor and interpretation likely to shape reception of any new claims about acetaminophen."
A forthcoming HHS autism report is expected to suggest an association between prenatal acetaminophen exposure and autism, note low folate levels, and mention folinic acid (leucovorin) as a possible mitigation for some individuals. HHS cautioned that conclusions should not be assumed until the final document is released, and Kenvue stated it sees no causal link after continual review of the science. Past claims have emphasized environmental toxins and an earlier MAHA report faced scrutiny for citing nonexistent or misinterpreted studies. A large 2024 JAMA sibling-control study of nearly 2.5 million Swedish children found no association between prenatal acetaminophen and autism, ADHD, or intellectual disability. Major medical groups continue to recommend prudent acetaminophen use in pregnancy when medically indicated. Kenvue shares fell sharply and have remained volatile after the news.
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]